In-silico Design of a Core Scaffold Pyrazolone Fused Heterocyclic Analogues as Dual Inhibitors Targeting Breast Cancer. (2021). Asian Journal of Pharmaceutical and Health Sciences, 11(2), 2468-2474. https://doi.org/10.5530/qsrddd17